Olanzapine Tablet, Orally Disintegrating
Product Images NDC 0093-5246

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 0093-5246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Image 1
Chemical structure diagram of olanzapine, showing the molecular structure with multiple rings including a thiazepine and piperazine ring system and methyl substituents.*
FDA Label Image

Image 2

Image 2
Packaging label for Olanzapine Orally Disintegrating Tablets, USP 5 mg by Teva Pharmaceuticals USA, Inc. The label indicates 30 tablets per carton (5 blister cards of 6 tablets each). The label includes dosage storage instructions, patient warnings, NDC 0093-5245-65, barcodes, and manufacturer information. Tablet strength is clearly marked in magenta.*
FDA Label Image

Image 3

Image 3
Olanzapine Orally Disintegrating Tablets USP 10 mg packaging label from Teva Pharmaceuticals USA, Inc. The carton indicates a 30-tablet supply (5 blister cards of 6 tablets each). The label includes administration instructions, storage conditions, and warnings. The design features the Teva logo and dosage strength prominently on the front panels.*
FDA Label Image

Image 4

Image 4
Packaging label for Olanzapine Orally Disintegrating Tablets, USP 15 mg by Teva Pharmaceuticals USA, Inc. The package contains 30 tablets divided into 5 blister cards of 6 tablets each. The label includes dosage form, strength, storage instructions, patient instructions, and warnings about phenylketonuria.*
FDA Label Image

Image 5

Image 5
Packaging label for Olanzapine Orally Disintegrating Tablets, USP 20 mg by Teva Pharmaceuticals USA, Inc. The label indicates each tablet contains 20 mg olanzapine and 4 mg phenylalanine. Package size is 30 tablets, arranged as 5 blister cards of 6 tablets each. Includes medication guide instructions and storage information with Teva logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.